Page 338 - v11i4
P. 338

International Journal of Bioprinting                                 GradGelMA 3D-bioprinted vascular skin




            repeatedly dropping a low-concentration gelatin solution   optimizing the culture parameters for epidermal cells,
            containing keratinocytes, ultimately resulting in a pre-  dermal cells, and vascular endothelial cells, we prepared
            vascularized multi-layered skin substitute. Despite these   a hydrogel-based, cell-compatible composite ink for VS.
            advances, significant challenges remain. Many studies   Using 3D extrusion printing technology, we constructed
            primarily assess endothelial cell viability without fully   a stable  in vitro dermal VS substitute. Additionally, the
            characterizing  in vitro microvascular  network formation   3D-printed VS was implanted into skin defect models to
            or functionality. Effective vascularization is critical for   further investigate its reparative effects on damaged tissue.
            nutrient delivery, oxygenation, and tissue integration, yet   We believe this study provides a promising skin substitute
            current methods often fail to recapitulate the hierarchical   for clinical applications and offers valuable insights for
            vascular networks found in native skin.            future research.
               Therefore, this study aimed to construct a multi-
            layered skin substitute with a vascularized structure. First,   2. Methods
            we modified gelatin with methacrylic anhydride to obtain   2.1. Three-dimensional bioprinting equipment
            GelMA hydrogels with different degrees of functionalization.   We independently developed a 3D bioprinting device. The
            We then characterized the physicochemical properties,   device comprises a temperature control module, a motion
            printability, and biocompatibility of the GelMA. By   module, a material supply module, and a control module.
            adjusting the concentration of GelMA solutions and   The constructed 3D bioprinting device is shown in Figure 1,



















































                                      Figure 1. Overall assembly diagram of the printing equipment system.


            Volume 11 Issue 4 (2025)                       330                            doi: 10.36922/IJB025090069
   333   334   335   336   337   338   339   340   341   342   343